Iqvia RDS (India) Private Limited

Iqvia RDS (India) Private Limited - information technology in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U74909KA2002PTC107115 Incorporated 21 November 2002 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company information technology
Data last updated
Revenue · FY 2025
₹3,342 Cr
▲ 6% YoY
Net profit · FY 2025
₹347.29 Cr
Net margin 10.4%
EBITDA · FY 2025
₹519.8 Cr
EBITDA margin 15.6%
Authorised capital
₹25.5 Cr
Registered with MCA
Paid-up capital
₹2.38 Cr
Issued & subscribed
Open charges
₹50,000
Satisfied ₹7.75 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
13,703
Provident fund records

About Iqvia RDS (India) Private Limited

Data last updated:

Iqvia RDS (India) Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Quintiles Mauritius Holdings. It operates in the database management and solutions segment of the technology and IT services sector. It was incorporated on 21 November 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74909KA2002PTC107115. Its GSTIN is 29AAACQ0935H1ZG (Karnataka). The company holds 10 GST registrations, of which 8 are active.

The company has an authorised share capital of ₹25.5 Cr and a paid-up capital of ₹2.38 Cr. It was formerly known as Quintiles Research (India) Private Limited. It is led by directors including Nilanjan Sinha and Gaurav Shankar Lal.

Its last annual general meeting (AGM) was held on 04 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Omega Embassy Techsquare Marathahalli – Sarjapur Outer Ring Road Kadubeesanahalli, Bangalore, Karnataka, India – 560103.

As per the financials filed for FY 2025, the company reported a revenue of ₹3,342 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹347.29 Cr (net margin 10.4%) and EBITDA of ₹519.8 Cr (EBITDA margin 15.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 16% over five years.

The company has about 13,703 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: IQVIA. As per MCA filings, the company has open charges of ₹50,000 and satisfied charges of ₹7.75 Cr on record. Court records list 9 cases involving the company, including 6 filed by the company and 3 filed against it; 1 case is pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2017. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 1 larger and 2 smaller; the largest is Syngene International Limited with revenue of ₹3,714.2 Cr. The company has 20 MSME Form 1 returns on record between 2019 and 2024, listing 2,904 overdue payments to 101 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website iqvia.com.

Company details

CIN U74909KA2002PTC107115
Registration Number 107115
Incorporation Date 21 November 2002
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 04 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Quintiles Mauritius Holdings
Compliance Status Active Compliant

CIN history

Iqvia RDS (India) has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74909KA2002PTC107115, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74909KA2002PTC107115Current
U73100GJ2002PTC074076Previous
U73100KA2002PTC107115Previous
U73100KA2002PTC031247Previous

Contact details

Iqvia RDS (India) Private Limited's registered office is in Bangalore, Karnataka.

  • Social Media
  • Registered Address
    Omega Embassy Techsquare Marathahalli – Sarjapur Outer Ring Road Kadubeesanahalli, Bangalore, Karnataka, India – 560103
  • Industry
    Information Technology, Database Management & Solutions
Comprehensive company report
Iqvia RDS (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Iqvia RDS (India) operates one associated brand: IQVIA. Each brand links to its own profile.

BrandDescriptionWebsite
Clinical research and commercialization solutions are provided for healthcare.iqvia.com

Business activity

The main business activity of Iqvia RDS (India) is professional, scientific and technical. In detail, this covers scientific research and development and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Iqvia RDS (India) Private Limited, buy the company report.

Financials of Iqvia RDS (India) Private Limited

FY 2025 filings available

Iqvia RDS (India) Private Limited reported revenue of ₹3,342 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹3,342 Cr ▲ 6%
Net profit · FY 2025
₹347.29 Cr margin 10.4%
EBITDA · FY 2025
₹519.8 Cr margin 15.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 11%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 4%
5 years · compounded
▲ 11%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 6% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹519.8 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹347.29 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.6%
Net Profit Margin10.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Iqvia RDS (India) Private Limited, buy the company report.

Board of directors of Iqvia RDS (India) Private Limited

Iqvia RDS (India) has 4 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Peer comparison

Iqvia RDS (India) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Syngene International Limited₹3,714.2 Cr (FY 2025)4.0%Bangalore, Karnataka, India
Iqvia RDS (India) Private Limitedthis company₹3,342 Cr (FY 2025)₹347.29 Cr10.4%6.0%Bangalore, Karnataka, India
Aragen Life Sciences Limited₹1,870.29 Cr (FY 2025)12.0%Hyderabad, Telangana, India
Sai Life Sciences Limited₹1,731.35 Cr (FY 2025)16.0%Hyderabad, Telangana, India

To see the full peer comparison of Iqvia RDS (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50,000
Satisfied charges
₹7.75 Cr
Breakdown by lending institutions
Citi Bank N.A.₹0.01 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 May 2024100923819Citi Bank N.A.₹50,000Open
31 Jul 2017100115252Citi Bank N.A.₹3.88 CrSatisfied
05 Apr 2017100090746Citi Bank N.A.₹3.87 CrSatisfied

To see the full charge records of Iqvia RDS (India) Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Iqvia RDS (India) Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2017.

Total deals
2
Secondary share transfers
2

Deals on record (2 of 2)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: IQVIA Inc
Seller: Quintiles Transnational Corporation
Feb 2012Secondary share transferUndisclosedSeller: Quintiles Mauritius Holdings Inc

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Iqvia RDS (India) Private Limited has 20 MSME Form 1 returns on record between 2019 and 2024, listing 2,904 overdue payments to 101 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 101)

SupplierAmount dueDue sinceReported on
an individual supplier
Abacus Staffing & Services Private Limited
Codinglimits Private Limited
Maiora IT Services and Consulting Private Limited
Superior Document

To see the full MSME payment records of Iqvia RDS (India) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Iqvia RDS (India) has 10 GST registrations: 8 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
10
Active
8
Cancelled / inactive
2
GSTINStateStatusRegistered on
29AAACQ0935H1ZGKarnatakaActive01 Jul 2017
29AAACQ0935H2ZFKarnatakaActive07 Jun 2024
24AAACQ0935H1ZQGujaratActive01 Jul 2017
27AAACQ0935H1ZKMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Iqvia RDS (India) Private Limited, buy the company report.

Recent activity

Iqvia RDS (India) Private Limited has 21 board changes on record since 2009: 4 appointments and 17 cessations. The latest: Madhvi Shankar ceased to be Additional Director on 02 Apr 2025.

AGM
Iqvia Rds (India) Private Limited last Annual general meeting of members was held on 04 Aug 2025 as per latest MCA records.
Ceased
Madhvi Shankar ceased to be Additional Director.
Ceased
Vineet Kumar Bajpai ceased to be Additional Director.
Filing
Iqvia Rds (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Madhvi Shankar was appointed as Director.
Appointed
Vineet Kumar Bajpai was appointed as Director.
Charges
A charge registered on 05 Apr 2017 via Charge ID 100090746 with Citi Bank N.A. was fully satisfied on 21 Jun 2024.
Charges
A charge with Citi Bank N.A. amounted to Rs. 0.01 Cr with Charge ID 100923819 was registered on 09 May 2024.
Ceased
Gaurav Shankar Lal ceased to be Additional Director.
Appointed
Gaurav Shankar Lal was appointed as Director.
Ceased
Stephen Thomas Simpson ceased to be Additional Director.
Charges
A charge registered on 31 Jul 2017 via Charge ID 100115252 with Citi Bank N.A. was fully satisfied on 12 Mar 2019.

17 earlier events are in the company report.

Frequently asked questions

Iqvia RDS (India) is an active private limited company based in Bangalore, Karnataka, India. The company works in database management and solutions, within the information technology industry. It was incorporated on 21 November 2002 (24+ years old) and is registered under CIN U74909KA2002PTC107115.

Iqvia RDS (India) has 4 current directors:

The latest financial statements of Iqvia RDS (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Iqvia RDS (India) is 29AAACQ0935H1ZG, registered in Karnataka. The company has 10 GST registrations in all, of which 8 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAACQ0935H2ZF (Karnataka), 24AAACQ0935H1ZQ (Gujarat), 27AAACQ0935H1ZK (Maharashtra).

The CIN (Corporate Identification Number) of Iqvia RDS (India) is U74909KA2002PTC107115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Iqvia RDS (India) has 9 court cases on record: 6 filed by the company and 3 filed against it. 1 is pending. Most are in the high courts.

Iqvia RDS (India) was incorporated on 21 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Bangalore.

Iqvia RDS (India) has 2 deals on record (2 secondary share transfers); the latest was in March 2017.

The peers of Iqvia RDS (India) by revenue are Syngene International Limited, Aragen Life Sciences Limited, Sai Life Sciences Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

Madhvi Shankar ceased to be Additional Director on 02 Apr 2025. Vineet Kumar Bajpai ceased to be Additional Director on 02 Apr 2025. Madhvi Shankar was appointed as Director on 01 Jan 2025. Iqvia RDS (India) has 21 board changes on record in total.

Iqvia RDS (India) has 20 MSME Form 1 returns on record between 2019 and 2024, listing 2,904 overdue payments to 101 micro and small suppliers. The latest return was filed on 19 Apr 2024.

Iqvia RDS (India) can be reached through the website iqvia.com. Its registered office is in Bangalore, Karnataka, India.